Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Xylem (XYL)

Xylem Q4 revenue up 7% to $2.3 billion; 2025 adjusted EPS guided $4.50 to $4.70

Positive Impact 3 of 5 earnings Written later

Xylem reported fourth-quarter 2024 revenue of $2.3 billion, up 7%, and full-year revenue of $8.6 billion, up 16% on a reported basis and 6% organically. Q4 reported EPS was $1.34 (up 22%) and adjusted EPS was $1.18 (up 19%); reported results include a non-recurring gain on remeasurement of its previously held Idrica equity interest. The company guided 2025 revenue of about $8.6 to $8.7 billion and adjusted EPS of $4.50 to $4.70, and declared a $0.40 quarterly dividend, up 11%.

Key points

  • Q4 2024 revenue $2.3 billion, up 7% on a reported and organic basis; orders $2.2 billion, up 7%
  • Q4 adjusted EPS $1.18, up 19%; reported EPS $1.34, up 22%, including a non-recurring Idrica remeasurement gain
  • 2025 guidance: revenue of about $8.6 to $8.7 billion, adjusted EBITDA margin of 21.3% to 21.8%, adjusted EPS of $4.50 to $4.70
  • First-quarter dividend of $0.40 per share, up 11%, payable March 19, 2025 to holders of record as of February 18, 2025

The filing

CompanyXylem (XYL)
Form8-K, current report
Filed with the SECFeb 4, 2025, 7:03 AM ET
Accession number0001524472-25-000010

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.